A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
Condition(s) studied
Investigational drug(s) / intervention(s)
Elecoglipron: Elecoglipron is administered orally once daily.
Semaglutide: Semaglutide is administered orally once daily.
Study summary
The purpose of this study is to evaluate the efficacy, safety, and tolerability of elecoglipron compared with oral semaglutide in adults with T2DM and increased cardiovascular risk that is inadequately managed alone or on stable treatment with other background glucose-lowering medication(s).
Eligibility
Primary outcome measure(s)
- Change from baseline in Hemoglobin A1c (HbA1c) — Baseline to Week 52
Trial sites (210)
| Facility | City | Region | Status |
|---|---|---|---|
| Research Site | Birmingham | Alabama | Not Yet Recruiting |
| Research Site | Mesa | Arizona | Not Yet Recruiting |
| Research Site | Phoenix | Arizona | Recruiting |
| Research Site | Tempe | Arizona | Not Yet Recruiting |
| Research Site | Covina | California | Not Yet Recruiting |
| Research Site | Encinitas | California | Recruiting |
| Research Site | Garden Grove | California | Not Yet Recruiting |
| Research Site | Loma Linda | California | Not Yet Recruiting |
| Research Site | Long Beach | California | Not Yet Recruiting |
| Research Site | Pomona | California | Recruiting |
| Research Site | Sacramento | California | Recruiting |
| Research Site | Bridgeport | Connecticut | Not Yet Recruiting |
| Research Site | Crystal River | Florida | Not Yet Recruiting |
| Research Site | Hollywood | Florida | Not Yet Recruiting |
| Research Site | Jacksonville | Florida | Not Yet Recruiting |
| Research Site | Lake City | Florida | Recruiting |
| Research Site | Leesburg | Florida | Recruiting |
| Research Site | Orlando | Florida | Not Yet Recruiting |
| Research Site | Lilburn | Georgia | Not Yet Recruiting |
| Research Site | Idaho Falls | Idaho | Not Yet Recruiting |
| Research Site | Melrose Park | Illinois | Not Yet Recruiting |
| Research Site | Evansville | Indiana | Not Yet Recruiting |
| Research Site | Ames | Iowa | Recruiting |
| Research Site | Wichita | Kansas | Not Yet Recruiting |
| Research Site | Bowling Green | Kentucky | Not Yet Recruiting |
| Research Site | Rockville | Maryland | Not Yet Recruiting |
| Research Site | Rockville | Maryland | Recruiting |
| Research Site | Southfield | Michigan | Not Yet Recruiting |
| Research Site | Minneapolis | Minnesota | Not Yet Recruiting |
| Research Site | Jefferson City | Missouri | Not Yet Recruiting |
| Research Site | Kansas City | Missouri | Not Yet Recruiting |
| Research Site | Omaha | Nebraska | Not Yet Recruiting |
| Research Site | Henderson | Nevada | Recruiting |
| Research Site | Las Vegas | Nevada | Not Yet Recruiting |
| Research Site | Albuquerque | New Mexico | Not Yet Recruiting |
| Research Site | Durham | North Carolina | Not Yet Recruiting |
| Research Site | Morehead City | North Carolina | Recruiting |
| Research Site | Raleigh | North Carolina | Not Yet Recruiting |
| Research Site | Statesville | North Carolina | Not Yet Recruiting |
| Research Site | Wilmington | North Carolina | Recruiting |
+ 170 more sites — see the full list on the official registry below.
On this site
📄 Ozempic (semaglutide) drug profile →More AstraZeneca trials in South Korea
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07662213 on ClinicalTrials.gov ↗ ← All trials in South Korea